Article

Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program

Department of Veterans Affairs Medical Center, West Haven, Connecticut, USA.
The American Journal of Gastroenterology (Impact Factor: 9.21). 06/2009; 104(7):1802-29. DOI: 10.1038/ajg.2009.191
Source: PubMed

ABSTRACT Cirrhosis represents the end stage of any chronic liver disease. Hepatitis C and alcohol are currently the main causes of cirrhosis in the United States. Although initially cirrhosis is compensated, it eventually becomes decompensated, as defined by the presence of ascites, variceal hemorrhage, encephalopathy, and/or jaundice. These management recommendations are divided according to the status, compensated or decompensated, of the cirrhotic patient, with a separate section for the screening, diagnosis, and management of hepatocellular carcinoma (HCC), as this applies to patients with both compensated and decompensated cirrhosis. In the compensated patient, the main objective is to prevent variceal hemorrhage and any practice that could lead to decompensation. In the decompensated patient, acute variceal hemorrhage and spontaneous bacterial peritonitis are severe complications that require hospitalization. Hepatorenal syndrome is also a severe complication of cirrhosis but one that usually occurs in patients who are already in the hospital and, as it represents an extreme of the hemodynamic alterations that lead to ascites formation, it is placed under treatment of ascites. Recent advances in the pathophysiology of the complications of cirrhosis have allowed for a more rational management of cirrhosis and also for the stratification of patients into different risk groups that require different management. These recommendations are based on evidence in the literature, mainly from randomized clinical trials and meta-analyses of these trials. When few or no data exist from well-designed prospective trials, emphasis is given to results from large series and consensus conferences with involvement of recognized experts. A rational management of cirrhosis will result in improvements in quality of life, treatment adherence, and, ultimately, in outcomes.

0 Bookmarks
 · 
97 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cirrhosis carries high morbidity and mortality due to various complications and decompensation, which can be decreased by following various practice guidelines, which are variedly followed in actual practice. This multicentric prospective/retrospective study was conducted over a 3 month period to assess actual care of patients with cirrhosis. 416 patients with cirrhosis (median age 53 years, 316 males) were included in the study. A comprehensive protocol was devised taking into account various practice guidelines. Patients were divided into 3 groups. Group 1: Newly diagnosed patients evaluated as per protocol. Group 2: Patients previously diagnosed at the study centers, past practices assessed. Group 3: patients diagnosed previously at non-study centers, their surveillance practices were assessed. Patients in the 3 groups were similar in terms of age and gender ratio. There was significant difference between varices screening practices amongst 3 groups, however there was similar nonselective beta blockers (NSBB)/endoscopic variceal ligation (EVL) prophylaxis practices. Ultrasound surveillance for ascites varied significantly amongst 3 groups. There was significant difference between antibiotic prophylaxis practice in high risk ascites patients between groups 1 and 2. Evaluation of renal function at baseline and ultrasound surveillance for hepatocellular carcinoma was significantly different in 3 groups. All patients in group 1 underwent SpO2 monitoring, however none in groups 2 or 3 previously had SpO2 monitoring. Surveillance and treatment practices for various complications of cirrhosis vary widely in real life and falls well short of goals. Presence of dedicated protocols helps in improving the way we care for our patients with cirrhosis.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Liver imaging is a highly evolving field with new imaging contrast agents and modalities. Knowledge of the different imaging options and what they have to offer in primary and metastatic liver disease is essential for appropriate diagnosis, staging, and prognosis in patients. This review summarizes the major imaging modalities in liver neoplasms and provides specific discussion of imaging hepatocellular carcinoma, cholangiocarcinoma, and colorectal liver metastases. The final sections provide an overview of presurgical imaging relevant to planning hepatectomies and ablative procedures. Copyright © 2015 Elsevier Inc. All rights reserved.
    Surgical Oncology Clinics of North America 01/2014; 24(1). DOI:10.1016/j.soc.2014.09.002 · 1.67 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The relationships between the serum mineral concentrations and the endoscopic findings of esophageal varices have been poorly investigated. In this study, we investigated hepatitis virus-positive patients who had undergone a liver biopsy (n = 576) and 75 patients with compensated cirrhosis in order to evaluate the association of the zinc value with the severity of liver fibrosis and esophageal varices. The mean zinc values decreased with the progression of fibrosis (METAVIR score; F0-1: 71.3 ± 11.3, F2: 68.9 ± 11.7, F3: 66.3 ± 11.8, F4: 63.9 ± 15.0). In the hepatitis virus-related compensated cirrhosis, the mean zinc value decreased with the severity of varices (patients without varices: 66.3 ± 12.6, patients with low-risk varices: 62.5 ± 13.7, patients with high-risk varices: 55.6 ± 13.0). The zinc value was significantly lower in patients with varices than in those without varices (59.3 ± 13.6 vs 66.3 ± 12.6, p<0.05). The zinc value was also significantly lower in the patients with a high risk of bleeding than in those with a low risk (55.6 ± 13.0 vs 64.6 ± 13.1, p<0.01). These findings suggest that the zinc value is not only an indicator of an abnormal metal metabolism, but is also a simple parameter associated with hepatitis virus-related various conditions, including the degree of liver fibrosis and the severity of esophageal varices in compensated cirrhosis.
    Journal of Clinical Biochemistry and Nutrition 09/2014; 55(2):147-52. DOI:10.3164/jcbn.14-33 · 2.29 Impact Factor

Preview

Download
5 Downloads
Available from